- Report
- May 2024
- 135 Pages
Global
From €6138EUR$6,499USD£5,223GBP
- Report
- April 2025
- 50 Pages
Global
From €2503EUR$2,650USD£2,130GBP
Etidronate is a drug used to treat endocrine and metabolic disorders. It is a bisphosphonate, a type of drug that helps to reduce the activity of cells that break down bone. Etidronate is used to treat conditions such as osteoporosis, Paget's disease, and hypercalcemia. It works by slowing down the rate at which bones are broken down and absorbed into the bloodstream. Etidronate is available in both oral and intravenous forms.
Etidronate is used to treat a variety of endocrine and metabolic disorders. It is used to reduce the risk of fractures in people with osteoporosis, to reduce bone pain and deformity in people with Paget's disease, and to reduce calcium levels in people with hypercalcemia. Etidronate is also used to reduce the risk of fractures in people with cancer who are receiving chemotherapy or radiation therapy.
Some companies in the Etidronate market include Merck, Pfizer, and Teva Pharmaceuticals. Show Less Read more